Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Short Interest Update

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) was the target of a large decrease in short interest in the month of January. As of January 15th, there was short interest totalling 200 shares, a decrease of 66.7% from the December 31st total of 600 shares. Based on an average daily volume of 800 shares, the days-to-cover ratio is currently 0.3 days.

Mosaic ImmunoEngineering Stock Performance

CPMV stock remained flat at $0.98 during trading on Wednesday. The company’s stock had a trading volume of 1 shares, compared to its average volume of 564. The stock has a market capitalization of $7.09 million, a price-to-earnings ratio of -6.53 and a beta of 0.27. The company has a fifty day simple moving average of $0.88 and a two-hundred day simple moving average of $0.88. Mosaic ImmunoEngineering has a one year low of $0.10 and a one year high of $1.13.

Mosaic ImmunoEngineering Company Profile

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.